Acasti Pharma reported $62.82M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Acasti Pharma USD 62.82M 732K Sep/2025
Addus HomeCare USD 1.12B 30.86M Mar/2026
Amarin USD 449.41M 9.87M Mar/2026
Cassava Sciences USD 68.14M 6.26M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Option Care Health USD 1.35B 24.68M Mar/2026
Organigram Holdings CAD 369.46M 20.33M Dec/2025
Tilray USD 1.58B 39.08M Sep/2025